##gff-version 3
##sequence-region Q9HBA0 1 871
Q9HBA0	UniProtKB	Chain	1	871	.	.	.	ID=PRO_0000215347;Note=Transient receptor potential cation channel subfamily V member 4	
Q9HBA0	UniProtKB	Topological domain	1	469	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Transmembrane	470	490	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Topological domain	491	507	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Transmembrane	508	534	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Topological domain	535	547	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Transmembrane	548	568	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Topological domain	569	572	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Transmembrane	573	593	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Topological domain	594	608	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Transmembrane	609	636	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Topological domain	637	665	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Intramembrane	666	685	.	.	.	Note=Pore-forming;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Topological domain	686	693	.	.	.	Note=Extracellular;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Transmembrane	694	722	.	.	.	Note=Helical;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Topological domain	723	871	.	.	.	Note=Cytoplasmic;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Repeat	237	266	.	.	.	Note=ANK 1	
Q9HBA0	UniProtKB	Repeat	284	313	.	.	.	Note=ANK 2	
Q9HBA0	UniProtKB	Repeat	369	398	.	.	.	Note=ANK 3	
Q9HBA0	UniProtKB	Nucleotide binding	236	239	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4DX2,ECO:0000269|PubMed:22702953;Dbxref=PMID:22702953	
Q9HBA0	UniProtKB	Region	249	251	.	.	.	Note=Phosphatidylinositol-1%2C4%2C5-trisphosphate binding;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:A0A1D5PXA5	
Q9HBA0	UniProtKB	Region	296	299	.	.	.	Note=Phosphatidylinositol-1%2C4%2C5-trisphosphate binding;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:A0A1D5PXA5	
Q9HBA0	UniProtKB	Region	812	831	.	.	.	Note=Interaction with calmodulin and ITPR3;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12724311,ECO:0000269|PubMed:18826956;Dbxref=PMID:12724311,PMID:18826956	
Q9HBA0	UniProtKB	Motif	679	682	.	.	.	Note=Selectivity filter;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O35433	
Q9HBA0	UniProtKB	Metal binding	682	682	.	.	.	Note=Calcium%3B shared with neighboring subunits;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9R186	
Q9HBA0	UniProtKB	Binding site	192	192	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4DX2,ECO:0000269|PubMed:22702953;Dbxref=PMID:22702953	
Q9HBA0	UniProtKB	Binding site	197	197	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4DX2,ECO:0000269|PubMed:22702953;Dbxref=PMID:22702953	
Q9HBA0	UniProtKB	Binding site	201	201	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4DX2,ECO:0000269|PubMed:22702953;Dbxref=PMID:22702953	
Q9HBA0	UniProtKB	Binding site	248	248	.	.	.	Note=ATP;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4DX2,ECO:0000269|PubMed:22702953;Dbxref=PMID:22702953	
Q9HBA0	UniProtKB	Binding site	344	344	.	.	.	Note=Phosphatidylinositol-1%2C4%2C5-trisphosphate;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:A0A1D5PXA5	
Q9HBA0	UniProtKB	Modified residue	110	110	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9EPK8	
Q9HBA0	UniProtKB	Modified residue	253	253	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9EPK8	
Q9HBA0	UniProtKB	Modified residue	805	805	.	.	.	Note=Phosphotyrosine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9EPK8	
Q9HBA0	UniProtKB	Modified residue	824	824	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q9EPK8	
Q9HBA0	UniProtKB	Alternative sequence	28	61	.	.	.	ID=VSP_026614;Note=In isoform 5. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:16293632;Dbxref=PMID:16293632	
Q9HBA0	UniProtKB	Alternative sequence	239	285	.	.	.	ID=VSP_026615;Note=In isoform 4 and isoform 6. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:16293632;Dbxref=PMID:16293632	
Q9HBA0	UniProtKB	Alternative sequence	385	444	.	.	.	ID=VSP_013436;Note=In isoform 2 and isoform 6. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:16293632,ECO:0000303|Ref.6;Dbxref=PMID:16293632	
Q9HBA0	UniProtKB	Alternative sequence	844	871	.	.	.	ID=VSP_013437;Note=In isoform 3. PLDSMGNPRCDGHQQGYPRKWRTDDAPL->RHLCRVRRKR;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:12692122;Dbxref=PMID:12692122	
Q9HBA0	UniProtKB	Natural variant	19	19	.	.	.	ID=VAR_052391;Note=Associated with lower sodium concentrations in serum%3B shows diminished response to hypotonic stress relative to wild-type. P->S;Dbxref=dbSNP:rs3742030	
Q9HBA0	UniProtKB	Natural variant	89	89	.	.	.	ID=VAR_064517;Note=In MTD%3B lethal form. T->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20425821;Dbxref=dbSNP:rs397514473,PMID:20425821	
Q9HBA0	UniProtKB	Natural variant	97	97	.	.	.	ID=VAR_067989;Note=In HMN8%3B loss of function mutation. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22526352;Dbxref=dbSNP:rs876661124,PMID:22526352	
Q9HBA0	UniProtKB	Natural variant	183	183	.	.	.	ID=VAR_064518;Note=Found in a patient with spondyloepiphyseal dysplasia Maroteaux type%3B decreased protein stability%3B increased ATP-binding. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20503319,ECO:0000269|PubMed:22702953;Dbxref=dbSNP:rs387906324,PMID:20503319,PMID:22702953	
Q9HBA0	UniProtKB	Natural variant	197	197	.	.	.	ID=VAR_064519;Note=In MTD%3B lethal form%3B decreased protein stability%3B reduced ATP-binding. K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20425821,ECO:0000269|PubMed:22702953;Dbxref=dbSNP:rs387906903,PMID:20425821,PMID:22702953	
Q9HBA0	UniProtKB	Natural variant	199	199	.	.	.	ID=VAR_064520;Note=In MTD%3B decreased protein stability. L->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20577006,ECO:0000269|PubMed:22702953;Dbxref=dbSNP:rs515726167,PMID:20577006,PMID:22702953	
Q9HBA0	UniProtKB	Natural variant	232	232	.	.	.	ID=VAR_067990;Note=In HMN8 and CMT2C%3B does not affect channel localization to plasma membrane%3B results in increased agonist-induced channel activity and increased basal intracellular calcium concentration%3B decreases ATP-binding%3B no effect on protein stability%3B decreases binding to membranes enriched in phosphatidylinositol-2%2C4-bisphosphate%3B causes increased cell death. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21288981,ECO:0000269|PubMed:22526352,ECO:0000269|PubMed:22702953,ECO:0000269|PubMed:25256292;Dbxref=dbSNP:rs387906904,PMID:21288981,PMID:22526352,PMID:22702953,PMID:25256292	
Q9HBA0	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_063528;Note=In CMT2C%3B increased agonist-induced channel activity%3B causes increased cell death%3B no effect on protein stability and ATP-binding. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20037586,ECO:0000269|PubMed:21288981,ECO:0000269|PubMed:22702953;Dbxref=dbSNP:rs267607146,PMID:20037586,PMID:21288981,PMID:22702953	
Q9HBA0	UniProtKB	Natural variant	269	269	.	.	.	ID=VAR_063529;Note=In HMN8 and CMT2C%3B increased agonist-induced channel activity and increased basal intracellular calcium concentration%3B slightly decreased protein stability and ATP-binding%3B decreases binding to membranes enriched in phosphatidylinositol-2%2C4-bisphosphate%3B causes increased cell death. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20037586,ECO:0000269|PubMed:20037587,ECO:0000269|PubMed:20037588,ECO:0000269|PubMed:21288981,ECO:0000269|PubMed:22702953,ECO:0000269|PubMed:25256292;Dbxref=dbSNP:rs267607144,PMID:20037586,PMID:20037587,PMID:20037588,PMID:21288981,PMID:22702953,PMID:25256292	
Q9HBA0	UniProtKB	Natural variant	270	270	.	.	.	ID=VAR_068498;Note=In FDAB%3B poorly expressed on the cell surface%3B mutant channels show a significantly reduced response to agonists. G->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21964574;Dbxref=dbSNP:rs387907220,PMID:21964574	
Q9HBA0	UniProtKB	Natural variant	271	271	.	.	.	ID=VAR_068499;Note=In FDAB%3B poorly expressed on the cell surface%3B mutant channels show a significantly reduced response to agonists. R->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21964574;Dbxref=dbSNP:rs387907219,PMID:21964574	
Q9HBA0	UniProtKB	Natural variant	273	273	.	.	.	ID=VAR_068500;Note=In FDAB%3B poorly expressed on the cell surface%3B mutant channels show a significantly reduced response to agonists. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21964574;Dbxref=dbSNP:rs515726170,PMID:21964574	
Q9HBA0	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_064521;Note=In SMDK%3B slightly increased ATP-binding%3B slightly decreased protein stability. E->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20577006,ECO:0000269|PubMed:22702953;Dbxref=dbSNP:rs267607148,PMID:20577006,PMID:22702953	
Q9HBA0	UniProtKB	Natural variant	295	295	.	.	.	ID=VAR_064522;Note=In MTD%3B impairs protein folding or stability. T->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20577006,ECO:0000269|PubMed:22702953;Dbxref=dbSNP:rs515726171,PMID:20577006,PMID:22702953	
Q9HBA0	UniProtKB	Natural variant	315	315	.	.	.	ID=VAR_063541;Note=In CMT2C%3B increased basal and agonist-induced channel activity%2C decreased protein stability%3B decreased ATP-binding%3B decreases binding to membranes enriched in phosphatidylinositol-2%2C4-bisphosphate%3B causes increased cell death. R->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20037588,ECO:0000269|PubMed:21115951,ECO:0000269|PubMed:22702953,ECO:0000269|PubMed:25256292;Dbxref=dbSNP:rs267607143,PMID:20037588,PMID:21115951,PMID:22702953,PMID:25256292	
Q9HBA0	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_063530;Note=In CMT2C and SPSMA%3B decreased protein stability%3B decreased ATP-binding. R->C;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20037587,ECO:0000269|PubMed:20037588;Dbxref=dbSNP:rs267607145,PMID:20037587,PMID:20037588	
Q9HBA0	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_067991;Note=In CMT2C%3B does not affect channel localization to plasma membrane%3B results in increased agonist-induced channel activity and increased basal intracellular calcium concentration%3B decreases protein stability%3B causes increased cell death. R->H;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21288981,ECO:0000269|PubMed:25256292;Dbxref=dbSNP:rs387906905,PMID:21288981,PMID:25256292	
Q9HBA0	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_062331;Note=In MTD%3B decreased protein stability%3B no effect on ATP-binding. I->F;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19232556,ECO:0000269|PubMed:20425821,ECO:0000269|PubMed:22702953;Dbxref=dbSNP:rs121912636,PMID:19232556,PMID:20425821,PMID:22702953	
Q9HBA0	UniProtKB	Natural variant	331	331	.	.	.	ID=VAR_064523;Note=In MTD%3B no effect on protein stability%3B no effect on ATP-binding. I->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20577006,ECO:0000269|PubMed:22702953;Dbxref=dbSNP:rs515726172,PMID:20577006,PMID:22702953	
Q9HBA0	UniProtKB	Natural variant	333	336	.	.	.	ID=VAR_067992;Note=In SMDK. Missing	
Q9HBA0	UniProtKB	Natural variant	333	333	.	.	.	ID=VAR_062332;Note=In SMDK%3B decreased protein stability%3B no effect on ATP-binding. D->G;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19232556,ECO:0000269|PubMed:22702953;Dbxref=dbSNP:rs121912634,PMID:19232556,PMID:22702953	
Q9HBA0	UniProtKB	Natural variant	342	342	.	.	.	ID=VAR_064524;Note=In MTD%3B decreased protein stability%3B decreased ATP-binding. V->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20577006,ECO:0000269|PubMed:22702953;Dbxref=dbSNP:rs515726152,PMID:20577006,PMID:22702953	
Q9HBA0	UniProtKB	Natural variant	471	471	.	.	.	ID=VAR_064525;Note=In MTD%3B lethal form. Missing;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20425821,ECO:0000269|PubMed:20577006;Dbxref=PMID:20425821,PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	542	542	.	.	.	ID=VAR_067993;Note=In CMT2C. S->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21115951;Dbxref=dbSNP:rs387906902,PMID:21115951	
Q9HBA0	UniProtKB	Natural variant	592	592	.	.	.	ID=VAR_064526;Note=In MTD. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20577006;Dbxref=dbSNP:rs515726158,PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	594	594	.	.	.	ID=VAR_062333;Note=In SMDK and PSTD. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19232556,ECO:0000269|PubMed:20503319,ECO:0000269|PubMed:20577006;Dbxref=dbSNP:rs77975504,PMID:19232556,PMID:20503319,PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	596	596	.	.	.	ID=VAR_064527;Note=In SMDK. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20577006;Dbxref=dbSNP:rs515726159,PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	600	600	.	.	.	ID=VAR_064528;Note=In SMDK. G->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20577006;Dbxref=dbSNP:rs515726160,PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	602	602	.	.	.	ID=VAR_064529;Note=Found in a patient with spondyloepiphyseal dysplasia Maroteaux type. Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20503319;Dbxref=dbSNP:rs267607150,PMID:20503319	
Q9HBA0	UniProtKB	Natural variant	604	604	.	.	.	ID=VAR_064530;Note=In MTD%3B lethal form. I->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20425821;Dbxref=dbSNP:rs515726161,PMID:20425821	
Q9HBA0	UniProtKB	Natural variant	616	616	.	.	.	ID=VAR_054805;Note=In BCYM3%3B results in a gain of function and a constitutive activation of the channel. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18587396;Dbxref=dbSNP:rs121912632,PMID:18587396	
Q9HBA0	UniProtKB	Natural variant	617	617	.	.	.	ID=VAR_064531;Note=In MTD. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20425821;Dbxref=dbSNP:rs515726162,PMID:20425821	
Q9HBA0	UniProtKB	Natural variant	618	618	.	.	.	ID=VAR_064532;Note=In MTD. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20425821,ECO:0000269|Ref.6;Dbxref=dbSNP:rs515726163,PMID:20425821	
Q9HBA0	UniProtKB	Natural variant	620	620	.	.	.	ID=VAR_054806;Note=In BCYM3%3B results in a gain of function and a constitutive activation of the channel. V->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18587396;Dbxref=dbSNP:rs121912633,PMID:18587396	
Q9HBA0	UniProtKB	Natural variant	625	625	.	.	.	ID=VAR_064533;Note=In SMDK. M->I;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20577006;Dbxref=dbSNP:rs515726164,PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	709	709	.	.	.	ID=VAR_064534;Note=In SMDK. L->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20577006;Dbxref=dbSNP:rs116571438,PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	716	716	.	.	.	ID=VAR_062334;Note=In SMDK. A->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19232556;Dbxref=dbSNP:rs121912635,PMID:19232556	
Q9HBA0	UniProtKB	Natural variant	775	775	.	.	.	ID=VAR_064535;Note=In MTD. R->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20577006;Dbxref=PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	777	777	.	.	.	ID=VAR_064536;Note=In SMDK. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20577006;Dbxref=dbSNP:rs515726165,PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	797	797	.	.	.	ID=VAR_064537;Note=In MTD and SMDK%3B also found in a patient with spondyloepiphyseal dysplasia Maroteaux type. E->K;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:20425821,ECO:0000269|PubMed:20503319,ECO:0000269|PubMed:20577006;Dbxref=dbSNP:rs267607149,PMID:20425821,PMID:20503319,PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	799	799	.	.	.	ID=VAR_064538;Note=In MTD. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20577006;Dbxref=dbSNP:rs267607147,PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	799	799	.	.	.	ID=VAR_062335;Note=In MTD%3B also found in a patient with spondyloepiphyseal dysplasia Maroteaux type. P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19232556,ECO:0000269|PubMed:20425821,ECO:0000269|PubMed:20503319,ECO:0000269|PubMed:20577006,ECO:0000269|PubMed:26249260;Dbxref=dbSNP:rs121912637,PMID:19232556,PMID:20425821,PMID:20503319,PMID:20577006,PMID:26249260	
Q9HBA0	UniProtKB	Natural variant	799	799	.	.	.	ID=VAR_064539;Note=In MTD. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20577006;Dbxref=dbSNP:rs121912637,PMID:20577006	
Q9HBA0	UniProtKB	Natural variant	799	799	.	.	.	ID=VAR_064540;Note=In MTD. P->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20577006;Dbxref=dbSNP:rs267607147,PMID:20577006	
Q9HBA0	UniProtKB	Mutagenesis	231	231	.	.	.	Note=Decreased ATP-binding. F->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:22702953;Dbxref=PMID:22702953	
Q9HBA0	UniProtKB	Mutagenesis	251	251	.	.	.	Note=No effect on channel activity. No effect on interaction with membranes enriched in phosphatidylinositol-2%2C4-bisphosphate. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25256292;Dbxref=PMID:25256292	
Q9HBA0	UniProtKB	Mutagenesis	296	296	.	.	.	Note=Loss of interaction with membranes enriched in phosphatidylinositol-2%2C4-bisphosphate%3B when associated with P-299. N->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25256292;Dbxref=PMID:25256292	
Q9HBA0	UniProtKB	Mutagenesis	299	299	.	.	.	Note=Strongly decreased interaction with membranes enriched in phosphatidylinositol-2%2C4-bisphosphate. Loss of interaction with membranes enriched in phosphatidylinositol-2%2C4-bisphosphate%3B when associated with D-296. H->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25256292;Dbxref=PMID:25256292	
Q9HBA0	UniProtKB	Mutagenesis	344	344	.	.	.	Note=No effect on channel activity. No effect on interaction with membranes enriched in phosphatidylinositol-2%2C4-bisphosphate. K->E;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25256292;Dbxref=PMID:25256292	
Q9HBA0	UniProtKB	Mutagenesis	816	821	.	.	.	Note=Loss of calmodulin binding%3B when associated with A-828. RLRRDR->ELEEDE	
Q9HBA0	UniProtKB	Mutagenesis	821	824	.	.	.	Note=Loss of calmodulin binding. RWSS->AASA	
Q9HBA0	UniProtKB	Mutagenesis	822	822	.	.	.	Note=Loss of Ca(2+) dependent current potentiation. W->A	
Q9HBA0	UniProtKB	Mutagenesis	828	828	.	.	.	Note=Loss of calmodulin binding%3B when associated with 816-ELEEDE-821. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12724311;Dbxref=PMID:12724311	
Q9HBA0	UniProtKB	Sequence conflict	385	385	.	.	.	Note=I->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HBA0	UniProtKB	Sequence conflict	452	452	.	.	.	Note=V->A;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HBA0	UniProtKB	Sequence conflict	781	781	.	.	.	Note=D->N;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HBA0	UniProtKB	Sequence conflict	820	820	.	.	.	Note=D->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HBA0	UniProtKB	Sequence conflict	861	861	.	.	.	Note=P->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HBA0	UniProtKB	Sequence conflict	867	867	.	.	.	Note=D->E;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q9HBA0	UniProtKB	Helix	151	159	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	164	166	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	169	175	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	183	185	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Beta strand	188	190	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	194	200	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	209	220	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	223	228	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Beta strand	234	239	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	241	247	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	251	260	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	271	273	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX2	
Q9HBA0	UniProtKB	Turn	276	279	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	288	294	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	298	306	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	324	331	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	336	356	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Beta strand	357	360	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	362	364	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX2	
Q9HBA0	UniProtKB	Helix	373	379	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
Q9HBA0	UniProtKB	Helix	383	395	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4DX1	
